spacer
home > directory > Datwyler Sealing Solutions
PHARMACEUTICAL INDUSTRY DIRECTORY

Datwyler Sealing Solutions

Datwyler Sealing Solutions
Datwyler Sealing Solutions is a leading industrial supplier and a key player in the global healthcare world. Our state-of-the-art solutions for drug packaging and medical devices, build on over 100 years of experience. Within our healthcare offering, we provide a unique range of products and services including the most advanced elastomer formulations, coatings, aluminum seals, and processing technologies. Based on a broad range of experience in the healthcare industry and extensive material science expertise, we offer a full service offering to better help our customers determine the ideal solution for their parenteral packaging needs. Partnering with the world’s top pharmaceutical and medical companies, we stand by our mission to ensure all patient’s safety and improve patients’ lives.
phone +41 41 875 11 23
email sealing.ch@datwyler.com
web https://sealing.datwyler.com/
email Militärstrasse 7 CH-6467 Schattdorf Switzerland
 
spacer

Member login

E-mail address:

Password:
Remember me

Industry Events

Clinical Trial Supply New England

24-25 March 2020, Boston, US

Following on from another successful conference Arena International will be returning with full force to Waltham in March to celebrate another edition of the Clinical Trial Supply show. 2020 will gather the key stakeholders in the clinical trials community, including the FDA, US Customs and Border Protection, Biogen, Sanofi, and Blueprint Medicines Corporation. With interactive session formats, fresh content and networking, the event will provide attendees with an unparalleled opportunity for collaboration between players across the whole industry.
More info >>

 
News and Press Releases

High Throughput Analytics Herald a Paradigm Shift in the Development of Biopharmaceuticals

Heilbronn/Dortmund August 2019: Biopharmaceuticals have revolutionized therapies of various diseases. In particular with regard to chronical and/or severe clinical conditions like multiple sclerosis, rheumatoid arthritis or cancer they are considered the future of treatment. Also economically biological drugs are on their way up: The global biopharmaceuticals market is anticipated to reach about 400 billion USD by 2025. Which strategic alignment will help best to fill a successful pipeline?
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement